TITLE

Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

AUTHOR(S)
Bhuta, Tushar; Ohlsson, Arne
PUB. DATE
July 1998
SOURCE
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul1999, Vol. 79 Issue 1, p26
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
67245708

 

Related Articles

  • Postnatal dexamethasone in preterm infants. Tarnow-Mordi, William; Mitra, Andy // BMJ: British Medical Journal (International Edition);11/27/99, Vol. 319 Issue 7222, p1385 

    Editorial. Focuses on the use of dexamethasone, a practice for the postnatal treatment or prevention of chronic lung disease in preterm infants. Side effects of dexamethasone; Result of randomized studies of postnatal dexamethasone; Concerns expressed by parents.

  • Minimising neonatal brain injury: how research in the past five years has changed my clinical practice. Levene, Malcolm // Archives of Disease in Childhood;Mar2007, Vol. 92 Issue 3, p261 

    With improving neonatal survival for extremely premature babies, the challenge for neonatology is to improve outcome of surviving babies. This review concentrates on best evidence emerging in recent years on prevention of brain damage by early administration of drugs as well as avoidance of...

  • The role of inflammation in the development of chronic lung disease in neonates. De Dooy, Jozef J.; Mahieu, Ludo M.; Van Bever, Hugo P. // European Journal of Pediatrics;2001, Vol. 160 Issue 8, p457 

    Chronic lung disease (CLD) has been associated with chorioamnionitis and upper respiratory tract colonisation with Ureaplasma urealyticum. The aim of this review is to describe the increasing evidence that inflammation plays a critical role in the early stages of CLD of the neonate. Ongoing lung...

  • Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Jefferies, Ann L. // Paediatrics & Child Health (1205-7088);Dec2012, Vol. 17 Issue 10, p573 

    Postnatal corticosteroids have been used for prevention and treatment of neonatal chronic lung disease (CLD) (also know as bronchopulmonary dysplasia), a significant cause of mortality and morbidity in preterm infants. As both dexamethasone and hydrocortisone administration within the first...

  • Postnatal dexamethasone affects neuromotor and cognitive function.  // Reactions Weekly;4/3/2004, Issue 995, p3 

    Discusses research being done on the effect of postnatal use of dexamethasone for the prevention of chronic lung disease of prematurity on neuromotor and cognitive function at school age. Reference to a study by T. F. Yeh et al, published in the March 25, 2004 issue of the "New England Journal...

  • Case 1: A premature infant with apneic spells. Smith, Ryan W.; Gordon, Michelle M.; Smith, W. Gary // Paediatrics & Child Health (1205-7088);Nov2013, Vol. 18 Issue 9, p497 

    The article focuses on the case of female infant aged 25 weeks with apneic spells. During the infant's stay at a tertiary-level neonatal intensive care unit (NICU), the patient encountered issues including prematurity, respiratory distress syndrome, chronic lung disease and patent ductus...

  • Neurodevelopmental defects after steroid treatment of premature lung disease. Johnson, K. E. // Thorax;Jun2004, Vol. 59 Issue 6, p464 

    There has been much controversy in recent years regarding the early use of postnatal corticosteroids to treat preterm infants with respiratory distress syndrome (RDS). Short term respiratory benefits must be weighed against the potential for detrimental neurodevelopmental effects. This study...

  • Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity. Yeh, Tsu F.; Lin, Yuh J.; Lin, Hung C.; Huang, Chao C.; Hsieh, Wu S.; Lin, Chyi H.; Tsai, Cheng H. // New England Journal of Medicine;3/25/2004, Vol. 350 Issue 13, p1304 

    Background: We studied the outcomes at school age in children who had participated in a double-blind, placebo-controlled trial of early postnatal dexamethasone therapy (initiated within 12 hours after birth) for the prevention of chronic lung disease of prematurity. Methods: Of the 262 children...

  • Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up. Rademaker, K. J.; de Vries, L. S.; Uiterwaal, C. S. P. M.; Groenendaal, F.; Grobbee, D. E.; van Bel, F. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jan2008, Vol. 93 Issue 1, pF58 

    The benefits versus the risks of postnatal administration of steroids in preterm-born infants are still debatable. This review examines the literature on postnatal hydrocortisone treatment for chronic lung disease (CLD) in preterm-born infants with a particular focus on the effects of such...

  • Optimal dose of dexamethasone debated. Stephenson, Michelle // Infectious Diseases in Children;Aug2008, Vol. 21 Issue 8, p43 

    The article discusses research on the optimal dose of dexamethasone in preterm infants at risk for chronic lung disease. It references a study by W. Onland et al published in a 2008 issue of the periodical "Pediatrics." The researchers determined the effects of lower and higher cumulative...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics